borderline significancep = 0.07
Patients with MAD ≥6 mm showed a trend toward a higher likelihood of the study endpoint than patients without, however with borderline significance (6.7% vs 1.2%; p = 0.07; Fig. 3 ).
Patients with MAD ≥6 mm showed a trend toward a higher likelihood of the study endpoint than patients without, however with borderline significance (6.7% vs 1.2%; p = 0.07; Fig. 3 ).
The presence of MAD ≥1 mm (0.9% vs 1.8%; p = 0.46), MAD ≥4 mm (1.6% vs 1.3%; p = 0.87), or MVP (3.5% vs 1.2%; p = 0.32) were not associated with the study endpoint, whereas patients with MAD ≥6 mm showed a trend toward a higher likelihood of the study endpoint (6.7% vs 1.2%; p = 0.07).